HL7 v2.7 Vocabulary
0.1.0 - ci-build

HL7 v2.7 Vocabulary, published by HL7/FO. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/frankoemig/hl7.v2.terminology.v27/ and changes regularly. See the Directory of published versions

## CodeSystem: Vaccines Administered (2.7 - 1.5.0) (Experimental)

Official URL: http://terminology.hl7.org/v2plusvocab/CodeSystem/PH_VaccinesAdministeredCVX_CDC_NIP | Version: 1.5.0
Active as of 2026-01-27 | Computable Name: PH_VaccinesAdministeredCVX_CDC_NIP
Other Identifiers: OID:2.16.840.1.113883.12.292
Copyright/Legal: HL7 Inc., 2026

Table of codes specifying the administered vaccines. The values are maintained by the US Centers of Disease Control. The code system is maintained by the CDC, and may be found at URL; https://phinvads.cdc.gov/vads/ViewCodeSystem.action?id=2.16.840.1.113883.12.292 The value set is maintained by the CDC and may be found at URL: https://phinvads.cdc.gov/vads/ViewValueSet.action?id=ABDEE003-77C3-48E7-B941-EBF92B6B81FC

This Code system is referenced in the content logical definition of the following value sets:

- PHVS_VaccinesAdministeredCVX_CDC_NIP

Properties

This code system defines the following properties for its concepts

Name | Code | URI | Type | Description
versionIntroduced | versionIntroduced | http://terminology.hl7.org/v2plusvocab/CodeSystem/Property#versionIntroduced | string | version when was this code introduced
versionDeprecated | versionDeprecated | http://terminology.hl7.org/v2plusvocab/CodeSystem/Property#versionDeprecated | string | version when was this code deprecated
status | status | http://hl7.org/fhir/concept-properties#status | code | A code that indicates the status of the concept. Typical values are active, experimental, deprecated, and retired
comment | comment | http://terminology.hl7.org/v2plusvocab/CodeSystem/Property#comment | string | A string that provides additional detail pertinent to the use or understanding of the concept
usage | usage | http://terminology.hl7.org/v2plusvocab/CodeSystem/Property#usage | string | usage notes for this code
modified | modified | http://terminology.hl7.org/v2plusvocab/CodeSystem/Property#modified | dateTime | date of last modification

Concepts

This case-sensitive code system `http://terminology.hl7.org/v2plusvocab/CodeSystem/PH_VaccinesAdministeredCVX_CDC_NIP` defines the following codes:

Code | Display | Definition | versionIntroduced | usage
01 | DTP | DTP | 2.3 | diphtheria, tetanus toxoids and pertussis vaccine
02 | OPV | OPV | 2.3 | poliovirus vaccine, live, oral
03 | MMR | MMR | 2.3 | measles, mumps and rubella virus vaccine
04 | M/R | M/R | 2.3 | measles and rubella virus vaccine
05 | measles | measles | 2.3 | measles virus vaccine
06 | rubella | rubella | 2.3 | rubella virus vaccine
07 | mumps | mumps | 2.3 | mumps virus vaccine
08 | Hep B, adolescent or pediatric | Hep B, adolescent or pediatric | 2.3 | hepatitis B vaccine, pediatric or pediatric/adolescent dosage
09 | Td (adult) | Td (adult) | 2.3 | tetanus and diphtheria toxoids, adsorbed for adult use
10 | IPV | IPV | 2.3 | poliovirus vaccine, inactivated
100 | pneumococcal conjugate | pneumococcal conjugate | 2.4 | pneumococcal conjugate vaccine, polyvalent
101 | typhoid, ViCPs | typhoid, ViCPs | 2.4 | typhoid Vi capsular polysaccharide vaccine
102 | DTP-Hib-Hep B | DTP-Hib-Hep B | 2.5 | DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine
103 | meningococcal C conjugate | meningococcal C conjugate | 2.5 | meningococcal C conjugate vaccine
104 | Hep A-Hep B | Hep A-Hep B | 2.5 | hepatitis A and hepatitis B vaccine
105 | vaccinia (smallpox) diluted | vaccinia (smallpox) diluted | 2.5 | vaccinia (smallpox) vaccine, diluted
106 | DTaP, 5 pertussis antigens6 | DTaP, 5 pertussis antigens6 | 2.5 | diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens
107 | DTaP, NOS | DTaP, NOS | 2.5 | diphtheria, tetanus toxoids and acellular pertussis vaccine, NOS
108 | meningococcal, NOS | meningococcal, NOS | 2.5 | meningococcal vaccine, NOS
109 | pneumococcal, NOS | pneumococcal, NOS | 2.5 | pneumococcal vaccine, NOS
11 | pertussis | pertussis | 2.3 | pertussis vaccine
110 | DTaP-Hep B-IPV | DTaP-Hep B-IPV | 2.6 | DTaP-hepatitis B and poliovirus vaccine
111 | influenza, live, intranasal | influenza, live, intranasal | 2.6 | influenza virus vaccine, live, attenuated, for intranasal use
112 | tetanus toxoid, NOS | tetanus toxoid, NOS | 2.6 | tetanus toxoid, NOS
113 | Td (adult) | Td (adult) | 2.6 | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use
114 | meningococcal A,C,Y,W-135 diphtheria conjugate | meningococcal A,C,Y,W-135 diphtheria conjugate | 2.6 | meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4)
115 | Tdap | Tdap | 2.6 | tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed
116 | rotavirus, pentavalent | rotavirus, pentavalent | 2.6 | rotavirus, live, pentavalent vaccine
117 | VZIG (IND) | VZIG (IND) | 2.6 | varicella zoster immune globulin (Investigational New Drug)
118 | HPV, bivalent | HPV, bivalent | 2.6 | human papilloma virus vaccine, bivalent
119 | rotavirus, monovalent | rotavirus, monovalent | 2.6 | rotavirus, live, monovalent vaccine
12 | diphtheria antitoxin | diphtheria antitoxin | 2.3 | diphtheria antitoxin
120 | DTaP-Hib-IPV | DTaP-Hib-IPV | 2.6 | diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)
121 | zoster | zoster | 2.6 | zoster vaccine, live
122 | rotavirus, NOS1 | rotavirus, NOS1 | 2.6 | rotavirus vaccine, NOS
13 | TIG | TIG | 2.3 | tetanus immune globulin
14 | IG, NOS | IG, NOS | 2.3 | immune globulin, NOS
15 | influenza, split (incl. purified surface antigen) | influenza, split (incl. purified surface antigen) | 2.3 | influenza virus vaccine, split virus (incl. purified surface antigen)
16 | influenza, whole | influenza, whole | 2.3 | influenza virus vaccine, whole virus
17 | Hib, NOS | Hib, NOS | 2.3 | Haemophilus influenzae type b vaccine, conjugate NOS
18 | rabies, intramuscular injection | rabies, intramuscular injection | 2.3 | rabies vaccine, for intramuscular injection
19 | BCG | BCG | 2.3 | Bacillus Calmette-Guerin vaccine
20 | DTaP | DTaP | 2.3 | diphtheria, tetanus toxoids and acellular pertussis vaccine
21 | varicella | varicella | 2.3 | varicella virus vaccine
22 | DTP-Hib | DTP-Hib | 2.3 | DTP-Haemophilus influenzae type b conjugate vaccine
23 | plague | plague | 2.3 | plague vaccine
24 | anthrax | anthrax | 2.3 | anthrax vaccine
25 | typhoid, oral | typhoid, oral | 2.3 | typhoid vaccine, live, oral
26 | cholera | cholera | 2.3 | cholera vaccine
27 | botulinum antitoxin | botulinum antitoxin | 2.3 | botulinum antitoxin
28 | DT (pediatric) | DT (pediatric) | 2.3 | diphtheria and tetanus toxoids, adsorbed for pediatric use
29 | CMVIG | CMVIG | 2.3 | cytomegalovirus immune globulin, intravenous
30 | HBIG | HBIG | 2.3 | hepatitis B immune globulin
31 | Hep A, pediatric, NOS | Hep A, pediatric, NOS | 2.3 | hepatitis A vaccine, pediatric dosage, NOS
32 | meningococcal | meningococcal | 2.3 | meningococcal polysaccharide vaccine (MPSV4)
33 | pneumococcal | pneumococcal | 2.3 | pneumococcal polysaccharide vaccine
34 | RIG | RIG | 2.3 | rabies immune globulin
35 | tetanus toxoid | tetanus toxoid | 2.3 | tetanus toxoid, adsorbed
36 | VZIG | VZIG | 2.3 | varicella zoster immune globulin
37 | yellow fever | yellow fever | 2.3 | yellow fever vaccine
38 | rubella/mumps | rubella/mumps | 2.3 | rubella and mumps virus vaccine
39 | Japanese encephalitis | Japanese encephalitis | 2.3 | Japanese encephalitis vaccine
40 | rabies, intradermal injection | rabies, intradermal injection | 2.3 | rabies vaccine, for intradermal injection
41 | typhoid, parenteral | typhoid, parenteral | 2.3 | typhoid vaccine, parenteral, other than acetone-killed, dried
42 | Hep B, adolescent/high risk infant2 | Hep B, adolescent/high risk infant2 | 2.3 | hepatitis B vaccine, adolescent/high risk infant dosage
43 | Hep B, adult4 | Hep B, adult4 | 2.3 | hepatitis B vaccine, adult dosage
44 | Hep B, dialysis | Hep B, dialysis | 2.3 | hepatitis B vaccine, dialysis patient dosage
45 | Hep B, NOS | Hep B, NOS | 2.3 | hepatitis B vaccine, NOS
46 | Hib (PRP-D) | Hib (PRP-D) | 2.3 | Haemophilus influenzae type b vaccine, PRP-D conjugate
47 | Hib (HbOC) | Hib (HbOC) | 2.3 | Haemophilus influenzae type b vaccine, HbOC conjugate
48 | Hib (PRP-T) | Hib (PRP-T) | 2.3 | Haemophilus influenzae type b vaccine, PRP-T conjugate
49 | Hib (PRP-OMP) | Hib (PRP-OMP) | 2.3 | Haemophilus influenzae type b vaccine, PRP-OMP conjugate
50 | DTaP-Hib | DTaP-Hib | 2.3 | DTaP-Haemophilus influenzae type b conjugate vaccine
51 | Hib-Hep B | Hib-Hep B | 2.3 | Haemophilus influenzae type b conjugate and Hepatitis B vaccine
52 | Hep A, adult | Hep A, adult | 2.3 | hepatitis A vaccine, adult dosage
53 | typhoid, parenteral, AKD (U.S. military) | typhoid, parenteral, AKD (U.S. military) | 2.3.1 | typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)
54 | adenovirus, type 4 | adenovirus, type 4 | 2.3.1 | adenovirus vaccine, type 4, live, oral
55 | adenovirus, type 7 | adenovirus, type 7 | 2.3.1 | adenovirus vaccine, type 7, live, oral
56 | dengue fever | dengue fever | 2.3.1 | dengue fever vaccine
57 | hantavirus | hantavirus | 2.3.1 | hantavirus vaccine
58 | Hep C | Hep C | 2.3.1 | hepatitis C vaccine
59 | Hep E | Hep E | 2.3.1 | hepatitis E vaccine
60 | herpes simplex 2 | herpes simplex 2 | 2.3.1 | herpes simplex virus, type 2 vaccine
61 | HIV | HIV | 2.3.1 | human immunodeficiency virus vaccine
62 | HPV, quadrivalent | HPV, quadrivalent | 2.3.1 | human papilloma virus vaccine, quadrivalent
63 | Junin virus | Junin virus | 2.3.1 | Junin virus vaccine
64 | leishmaniasis | leishmaniasis | 2.3.1 | leishmaniasis vaccine
65 | leprosy | leprosy | 2.3.1 | leprosy vaccine
66 | Lyme disease | Lyme disease | 2.3.1 | Lyme disease vaccine
67 | malaria | malaria | 2.3.1 | malaria vaccine
68 | melanoma | melanoma | 2.3.1 | melanoma vaccine
69 | parainfluenza-3 | parainfluenza-3 | 2.3.1 | parainfluenza-3 virus vaccine
70 | Q fever | Q fever | 2.3.1 | Q fever vaccine
71 | RSV-IGIV | RSV-IGIV | 2.3.1 | respiratory syncytial virus immune globulin, intravenous
72 | rheumatic fever | rheumatic fever | 2.3.1 | rheumatic fever vaccine
73 | Rift Valley fever | Rift Valley fever | 2.3.1 | Rift Valley fever vaccine
74 | rotavirus, tetravalent | rotavirus, tetravalent | 2.3.1 | rotavirus, live, tetravalent vaccine
75 | vaccinia (smallpox) | vaccinia (smallpox) | 2.3.1 | vaccinia (smallpox) vaccine
76 | Staphylococcus bacterio lysate | Staphylococcus bacterio lysate | 2.3.1 | Staphylococcus bacteriophage lysate
77 | tick-borne encephalitis | tick-borne encephalitis | 2.3.1 | tick-borne encephalitis vaccine
78 | tularemia vaccine | tularemia vaccine | 2.3.1 | tularemia vaccine
79 | vaccinia immune globulin | vaccinia immune globulin | 2.3.1 | vaccinia immune globulin
80 | VEE, live | VEE, live | 2.3.1 | Venezuelan equine encephalitis, live, attenuated
81 | VEE, inactivated | VEE, inactivated | 2.3.1 | Venezuelan equine encephalitis, inactivated
82 | adenovirus, NOS1 | adenovirus, NOS1 | 2.3.1 | adenovirus vaccine, NOS
83 | Hep A, ped/adol, 2 dose | Hep A, ped/adol, 2 dose | 2.3.1 | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule
84 | Hep A, ped/adol, 3 dose | Hep A, ped/adol, 3 dose | 2.3.1 | hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule
85 | Hep A, NOS | Hep A, NOS | 2.3.1 | hepatitis A vaccine, NOS
86 | IG | IG | 2.3.1 | immune globulin, intramuscular
87 | IGIV | IGIV | 2.3.1 | immune globulin, intravenous
88 | influenza, NOS | influenza, NOS | 2.3.1 | influenza virus vaccine, NOS
89 | polio, NOS | polio, NOS | 2.3.1 | poliovirus vaccine, NOS
90 | rabies, NOS | rabies, NOS | 2.3.1 | rabies vaccine, NOS
91 | typhoid, NOS | typhoid, NOS | 2.3.1 | typhoid vaccine, NOS
92 | VEE, NOS | VEE, NOS | 2.3.1 | Venezuelan equine encephalitis vaccine, NOS
93 | RSV-MAb | RSV-MAb | 2.4 | respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular
94 | MMRV | MMRV | 2.4 | measles, mumps, rubella, and varicella virus vaccine
95 | TST-OT tine test | TST-OT tine test | 2.4 | tuberculin skin test; old tuberculin, multipuncture device
96 | TST-PPD intradermal | TST-PPD intradermal | 2.4 | tuberculin skin test; purified protein derivative solution, intradermal
97 | TST-PPD tine test | TST-PPD tine test | 2.4 | tuberculin skin test; purified protein derivative, multipuncture device
98 | TST, NOS | TST, NOS | 2.4 | tuberculin skin test; NOS
99 | RESERVED - do not use3 | RESERVED - do not use3 | 2.4 | RESERVED - do not use
998 | no vaccine administered5 | no vaccine administered5 | 2.5 | no vaccine administered
999 | unknown | unknown | 2.4 | unknown vaccine or immune globulin